Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 3Phase 3 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 6NETWORK 3INDUSTRY 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 2Sarcoma 1

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Sarcoma 1Bone Neoplasms 1

Interventions

Cisplatin 24Radiotherapy 18Carboplatin 18Paclitaxel 17Vincristine 15Cyclophosphamide 14Etoposide 13Filgrastim 12Doxorubicin 12Gemcitabine 11Temozolomide 10Cytarabine 9Topotecan 8Docetaxel 8Methotrexate 7Irinotecan 7Granulocyte Colony-Stimulating Factor 7Dexamethasone 7Taxes 6Radiation 6Peripheral Blood Stem Cell Transplantation 6Radiotherapy, Conformal 5Oxaliplatin 5Melphalan 5Fenretinide 5Chemotherapy, Adjuvant 5Capecitabine 5etoposide phosphate 4Trastuzumab 4Platinum 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × NETWORK × Trabectedin × Clear all
NCT02398058 2021-04-14

TOMAS

Italian Sarcoma Group

Phase 1 Completed
50 enrolled
Sarcoma

Bone Neoplasms, Sarcoma

NCT00006463 2014-02-21

Ecteinascidin 743 in Treating Children With Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
13 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00002904 2012-07-02

Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
40 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡